Accreditation and Designation User Manual - OECI

More documents

Recommendations

Info

The keyword in the designation of European cancer institutes is the level of comprehensiveness of both professional infrastructure and performance. The philosophy behind comprehensiveness is: “If all relevant competences, skills, resources and tools concerning cancer care and research are brought together and integrated, it will lead to an outcome that is larger, on the whole, than the sum of its parts” (Ringborg, 2008). Comprehensiveness, in that sense, can be seen as the new basic principle on how cancer activities institutionally should be organised. Four different types of cancer institutes/organisations will be distinguished: Cancer Unit, (Specialised) Clinical Cancer Centre, Cancer Research Centre and Comprehensive Cancer Centre (CCC). The definition of each category is given in Table 1. The type of cancer organisation indicates the comprehensiveness of the services and the degree of specialisation. The objective of designation A designation system in combination with an exclusive OECI accreditation programme for each designation type of cancer centre will create platforms in which synchronization and benchmarking of cancer institutes will be possible on a European scale. Definitions of the designation categories are: − Cancer Units are defined as clinical facilities or hospital departments covering at least radiotherapy and medical or surgical oncology. Additionally they have a formalized collaboration with other hospital specialties. − The ‘Clinical Cancer Centre’ is characterised by the clinical capacity covering a sufficient degree of all medical, surgical and radiotherapy services and occasionally a limited degree of clinical research. − The ‘Cancer Research Centre’, is characterised by the capacity in cancer research focusing on one or more areas in the field of fundamental and translational oncology. − The ‘Comprehensive Cancer Centre’ (CCC) is probably the hardest category to define as many different interpretations on a CCC already exist. Based on available information and many definitions on the concept of a CCC, the following features are considered to be essential for this particular category: • A highly innovative character and multidisciplinary approach using the potential of basic, translational and clinical research and clinical facilities and activities, organised in a sufficiently identifiable entity, • A direct provision of an extensive variety of cancer care tailored to the individual patient’s needs and directed towards learning and improving the professional, organisational and relational quality of care, • Broad activities in the area of prevention, education, and external dissemination of knowledge and innovation. In order to accentuate the differences with other cancer centres, a CCC separates itself in the following points: • High level of infrastructure, expertise and innovation in the field of oncology research, • Maintenance of an extensive network including all aspects of oncology treatment and research, • Related to an academic/university centre or is an academic centre. Glossary Both questionnaires contain a glossary (doc 42). The intention of the glossary is to provide the user with the meaning of unclear or unknown words; for understanding and interpretation of the questions. Owner: OECI Organisation of European Cancer Institutes Status: Revised - 24 th January 2011 - A&D Working Group Approved by: OECI Accreditation and Designation Board Chapter 1 Introduction of the OECI A&D Programme Page 1 of 2 Version 16 February 2011
2 Timeline of the OECI A&D process 2.1 In ten steps to A&D certification It takes ten steps in the OECI A&D Programme towards OECI A&D certification. Figure 1 presents the ten steps preceded by one of the conditions for application, OECI membership. The ten steps include the essential decision moments for continuation of the institute in the programme. And, for monitoring continuous and comprehensive quality improvement in the institute there will be a follow-up of the institute’s improvement plan one year after certification. A detailed explanation of all steps is outlined in Chapter 5. Figure 1: Timeline A&D process Owner: OECI Organisation of European Cancer Institutes Status: Revised - 24 th January 2011 - A&D Working Group Approved by: OECI Accreditation and Designation Board Chapter 2 Timeline of the OECI A&D process Page 1 of 2 Version 16 February 2011
Page 1: ORGANISATION OF EUROPEAN CANCER INS
Page 4 and 5: OECI Accreditation and Designation
Page 6 and 7: THE OECI Accreditation and Designat
Page 8 and 9: Owner: OECI Organisation of Europea
Page 12 and 13: 2.1.1 General explanation of the te
Page 14 and 15: OECI General Assembly Member Instit
Page 16 and 17: − Organizing the auditors’ meet
Page 18 and 19: 3.2 Audit team and auditors 3.2.1 O
Page 20 and 21: 3.3 Cancer institute Obviously all
Page 24 and 25: 5.1.1 Step 1: activities and respon
Page 26 and 27: Designation questionnaire Executor:
Page 28 and 29: Send signed accreditation and desig
Page 30 and 31: 5.3 Step 3: Explanatory visit and p
Page 34 and 35: Finishing self-assesment Executor:
Page 36 and 37: 5.6 Step 6: Payment stage 2 fee If
Page 38 and 39: Preparation of the auditors’ team
Page 40 and 41: Performing the peer review Executor
Page 42 and 43: 5.8.1 Week 1-6: Reporting by the au
Page 46 and 47: 5.9 Step 9: Formulate improvement p
Page 48 and 49: 5.10.1 Evaluation of the A&D Progra
Page 50 and 51: Intermediate self-assessment (optio
Page 58 and 59: 2 / OECI Accreditation and Designat
Page 60 and 61:
Qualitative Questionnaire 1. Genera
Page 62 and 63:
1.3.2. Administration of cytostatic
Page 64 and 65:
1.4.6. Roles and tasks of the membe
Page 66 and 67:
1.4.12. Registration and evaluation
Page 68 and 69:
1.5.5. Quality assurance in all are
Page 70 and 71:
2.4.5. Smoking control in the cance
Page 72 and 73:
3.4.4. Palliative and terminal care
Page 74 and 75:
4. Research, innovation and develop
Page 76 and 77:
4.3. Resources and materials 4.3.1.
Page 78 and 79:
5. Teaching and continuing educatio
Page 80 and 81:
6. Patient related 6.4. Process con
Page 82 and 83:
6.5. Safeguarding the quality syste
Page 84 and 85:
1.4.7. at national level at regiona
Page 86 and 87:
2.3. Infrastructures with a focus o
Page 88 and 89:
2.9. Radiology 2.9.1. Number of CT
Page 90 and 91:
2.15. Facilities 2.15.1. On site Ac
Page 92 and 93:
3.4. Human resources (4) 3.4.1. Pat
Page 94 and 95:
4.3. Structures 4.3.1. Yes No not a
Page 96 and 97:
5. Education 5.1. Education 5.1.1.
Page 98 and 99:
Planning of the project Start Expla
Page 100 and 101:
Go to the qualitative and quantitat
Page 102 and 103:
3. Before moving to the next item p
Page 104 and 105:
The following screen will appear. F
Page 106 and 107:
• Close the questionnaire if you
Page 108 and 109:
Print only the questions or the ful
Page 110 and 111:
Workspace: Go to the questionnaires
Page 112 and 113:
2. Preparing a peer review Open a q
Page 114 and 115:
To view the remarks and the score o
Page 116 and 117:
2 / OECI Accreditation and Designat
Page 118 and 119:
Qualitative Questionnaire 1. Genera
Page 120 and 121:
1.3.2. Administration of cytostatic
Page 122 and 123:
1.4.6. Roles and tasks of the membe
Page 124 and 125:
1.4.12. Registration and evaluation
Page 126 and 127:
1.5.5. Quality assurance in all are
Page 128 and 129:
2.4.5. Smoking control in the cance
Page 130 and 131:
3.4.4. Palliative and terminal care
Page 132 and 133:
4. Research, innovation and develop
Page 134 and 135:
4.3. Resources and materials 4.3.1.
Page 136 and 137:
5. Teaching and continuing educatio
Page 138 and 139:
6. Patient related 6.4. Process con
Page 140 and 141:
6.5. Safeguarding the quality syste
Page 142 and 143:
1.4.7. at national level at regiona
Page 144 and 145:
2.3. Infrastructures with a focus o
Page 146 and 147:
2.9. Radiology 2.9.1. Number of CT
Page 148 and 149:
2.15. Facilities 2.15.1. On site Ac
Page 150 and 151:
3.4. Human resources (4) 3.4.1. Pat
Page 152 and 153:
4.3. Structures 4.3.1. Yes No not a
Page 154 and 155:
5. Education 5.1. Education 5.1.1.
Page 156 and 157:
Planning of the project Start Expla
Page 158 and 159:
Go to the qualitative and quantitat
Page 160 and 161:
3. Before moving to the next item p
Page 162 and 163:
The following screen will appear. F
Page 164 and 165:
• Close the questionnaire if you
Page 166 and 167:
Print only the questions or the ful
Page 168 and 169:
Workspace: Go to the questionnaires
Page 170 and 171:
2. Preparing a peer review Open a q
Page 172:
To view the remarks and the score o
show all

Accreditation and Designation User Manual - OECI

Create successful ePaper yourself

Delete template?

Save as template?